Mirae Asset Global Investments
CUE icon

Mirae Asset Global Investments’s Cue Biopharma CUE Stock Holding History

Mirae Asset Global Investments’s Portfolio CUE Stock Details CUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-701
Closed -$76.8K – 2582
2023
Q2 		$76.8K Buy
+701
New +$82.4K ﹤0.01% 2564

Other funds holding CUE

SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $3.57B AUM 28.36% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Mirae Asset Global Investments's CUE Position: Q3 2023 in Review

Mirae Asset Global Investments sold out of Cue Biopharma (CUE) in Q3 2023, closing a stake of 701 shares — an estimated $76.8K sold.

Mirae Asset Global Investments first reported a position in CUE in Q2 2023 and held it in 1 quarter. The position peaked at $76.8K in Q2 2023. 75 funds tracked by Wall St. Rank hold CUE as of Q3 2023.

  • Mirae Asset Global Investments reported no remaining Cue Biopharma position as of Q3 2023 after selling out during the quarter.
  • Mirae Asset Global Investments sold 701 Cue Biopharma shares in Q3 2023, an estimated $76.8K.
  • Mirae Asset Global Investments first reported a position in Cue Biopharma in Q2 2023 and held it in 1 quarter.
  • Mirae Asset Global Investments's Cue Biopharma position peaked at $76.8K in Q2 2023.
  • 75 funds tracked by Wall St. Rank held Cue Biopharma as of Q3 2023.

Based on Mirae Asset Global Investments's 13F filing for Q3 2023, filed 26 Oct 2023.